The U.S. Food and Drug Administration has approved Cymbalta for chronic back pain and osteoarthritis pain, according to a FDA news release. Cymbalta, which was first used to treat major depressive ...
INDIANAPOLIS A pain drug made by Eli Lilly & Co. “significantly” reduced chronic low back pain compared with placebo, according to a study announced Wednesday by Lilly. The double-blind study, ...
The FDA has approved duloxetine (Cymbalta) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic low-back pain. Several recent randomized trials have evaluated ...
Medically reviewed by Erika Prouty, PharmD Key Takeaways Over-the-counter (OTC) medications like NSAIDs and Tylenol can help relieve mild to moderate back pain.Be careful using Tylenol if you've had ...
Despite being prescribed fairly commonly, a new study has found that antidepressants provide little to no benefit when it comes to relieving low back pain and sciatica. More research is needed into ...
CHICAGO (Reuters) - Eli Lilly and Co said on Friday it withdrew an application to market its anti-depressant Cymbalta for the management of chronic pain because U.S. health regulators raised questions ...